Atlas Trials

Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab

Clinical trial NCT01123356 · COMPLETED

Trial details

NCT number
NCT01123356
Sponsor
Medical University of South Carolina
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Lymphocytic Leukemia
Start date
2010-05-01
Primary completion
2013-05-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.